Business tycoon Elon Musk’s Neuralink announced that it has secured approval from the U.S. Food and Drug Administration to begin its “first-in-human clinical study.” “We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study! This is the result of incredible work by the Neuralink team in close […]
The post is from MAD MAD NEWS